Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

A Shi Tzu dog with high cortisol levels improved after increasing the dose of trilostane.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Higher platelet doses in PRP therapy improve outcomes for musculoskeletal issues.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Platelet-rich plasma is as effective as mineral trioxide aggregate for pulp capping and may offer better cellular responses.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

GhPLDα1 helps thicken cotton fiber walls by boosting cellulose production.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Different people show different symptoms for genetic diseases because of how sensitive their bodies are to small changes in important factors.

Developing human skin has immune cells with memory-like features.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Key proteins and potential drugs for treating alopecia areata were identified.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Blocking testosterone speeds up wound healing in males.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Air pollution harms skin health and can worsen skin diseases.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.